Drug Database · Clinicians

Diphenydramine

Brands (1) BenadrylShow all

US brand (reference label): Nighttime Sleep Aid; not a Philippine-registered brand.

Antihistamine PH FDA category

OTC · Over-the-counter1 PH product
Dispensing: Over-the-counter (OTC) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID fc7ed67f-bac9-f9ed-e053-6294a90ad9a1, version date December 16, 2023 (Nighttime Sleep Aid · TARGET CORPORATION). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses ■ for relief of occasional sleeplessness
US FDA label
Full indications and usage US FDA label

Uses ■ for relief of occasional sleeplessness

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions Do not take more than directed. See overdose warning adults and children 12 years and over take 2 caplets at bedtime if needed, or as directed by a doctor children under 12 years do not use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 12.5 mg/5 mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Diphenydramine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Diphenydramine
Package insert
BenadrylDiphenydramine hydrochloride
12.5 mg/5 mL SyrupAmber glass bottle x 60 mL (Box of 1's); Amber glass bottle x 120 mL (Box of 1's)
OTC
Interphil Laboratories Inc.Philippines
Johnson & Johnson (Philippines), Inc.Trader: Johnson & Johnson Pte. Ltd.
DR-4619
Apr 16, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Do not use ■ in children under 12 years of age ■ with any other product containing diphenhydramine, even one used on skin Ask a doctor before use if you have ■ a breathing problem such as emphysema or chronic bronchitis ■ glaucoma ■ trouble urinating due to an enlarged prostrate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product ■ avoid alcoholic drinks ■ drowsiness will occur ■ do not drive a motor vehicle or operate machinery Stop use and ask a doctor if ■ sleeplessness persists continuously for more than 2 weeks. Insomnia may be a symptom of serious underlying medical illness.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Nighttime Sleep Aid · TARGET CORPORATION [US FDA-approved label, version 2, December 16, 2023]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc7ed67f-bac9-f9ed-e053-6294a90ad9a1
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .